Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Read

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Thrombosis Research|December 15, 1986
A paradoxical effect of antibody concentration on vWF-dependent platelet agglutination distinguishes between botrocetin and ristocetin-induced agglutinationD W Roberson, G R Upchurch, M A Lamb, et al.
Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Gene Therapy|March 1, 1996
Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogsB Fang, H Wang, G Gordon, et al.
Antisense & Nucleic Acid Drug Development|January 26, 1999
Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observedZ Zhang, M Eriksson, G Falk, et al.
Circulation|June 1, 1991
Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigsT C Nichols, D A Bellinger, R L Reddick, et al.
Gene Therapy|April 16, 1998
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophiliaP E Monahan, R J Samulski, J Tazelaar, et al.
British Journal of Haematology|November 25, 2000
Intracellular function in rehydrated lyophilized plateletsT H Fischer, E P Merricks, K E Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factorD A Bellinger, T C Nichols, M S Read, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1990
von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosisT C Nichols, D A Bellinger, D A Tate, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Thrombosis Research|December 15, 1986
A paradoxical effect of antibody concentration on vWF-dependent platelet agglutination distinguishes between botrocetin and ristocetin-induced agglutinationD W Roberson, G R Upchurch, M A Lamb, et al.
Thrombosis and Haemostasis|May 1, 1997
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Extravascular administration of factor IX: potential for replacement therapy of canine and human hemophilia BD Liles, C N Landen, D M Monroe, et al.
Gene Therapy|March 1, 1996
Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogsB Fang, H Wang, G Gordon, et al.
Antisense & Nucleic Acid Drug Development|January 26, 1999
Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observedZ Zhang, M Eriksson, G Falk, et al.
Circulation|June 1, 1991
Role of von Willebrand factor in arterial thrombosis. Studies in normal and von Willebrand disease pigsT C Nichols, D A Bellinger, R L Reddick, et al.
Gene Therapy|April 16, 1998
Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophiliaP E Monahan, R J Samulski, J Tazelaar, et al.
British Journal of Haematology|November 25, 2000
Intracellular function in rehydrated lyophilized plateletsT H Fischer, E P Merricks, K E Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factorD A Bellinger, T C Nichols, M S Read, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1990
von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosisT C Nichols, D A Bellinger, D A Tate, et al.
Pageof 9